Introduction {#S0001}
============

Vitamin D is a steroid hormone that can be synthesized in the skin after exposure to ultraviolet light and can also be obtained through exogenous supplementation or dietary intake.[@CIT0001] Epidemiological studies have shown that vitamin D deficiency affects nearly one billion people worldwide.[@CIT0002] Vitamin D deficiency is more severe in adults, especially in the Middle East and Asia.[@CIT0003] The prevalence of vitamin D deficiency varies by geographical location, duration of sunlight, use of sunscreen, and dietary habits.[@CIT0004] A recent multi-centric study in five major cities in China[@CIT0005] found that the prevalence of vitamin D deficiency in mainland urban population was 55.9%, and the serum level of 25-hydroxyvitamin D \[25(OH)D\] was \<50 nmol/L. Other studies have shown that the prevalence of vitamin D deficiency in adult men and women in the United States ranged from 40% to 100%.[@CIT0006]

Vitamin D plays an important role in maintaining bone health and mineral homeostasis. Vitamin D receptors are widely distributed in most tissues, and vitamin D has various important exoskeletal effects. Recent studies have confirmed that vitamin D is also involved in the metabolic regulation of nutrients in the body, such as sugar and fat.[@CIT0001] To the subjects with overweight and obesity, serum vitamin D levels were associated with body mass index (BMI), waist circumference (WC), fat mass, hyperinsulinemia, insulin resistance, and inflammatory markers, such as C-reactive protein, complement C~3~, and complement C~4~.[@CIT0007],[@CIT0008] De Pergola et al reported vitamin D deficiency was significantly associated to autoimmune thyroiditis in overweight and obese subjects.[@CIT0009] In animal models with vitamin D deficiency, supplementation improved insulin and glucose homeostasis.[@CIT0010],[@CIT0011] In addition, studies have shown that vitamin D deficiency increases the risk of hypertension and cardiovascular disease.[@CIT0012] Although numerous studies have shown a correlation between vitamin D and glycolipid metabolism, studies on vitamin D deficiency and its relationship with glycolipid metabolism in China, especially in Gansu province, are relatively rare.

Subjects and Methods {#S0002}
====================

Subjects {#S0002-S2001}
--------

A total of 1928 volunteers (aged 18--87 years) were selected to participate in the National Survey Of Diabetes Prevalence in Gansu province, including 958 males and 970 females. The survey and blood collection took place during December 2015 and May 2016.

Inclusion criteria: age ≥18 years, Han nationality, at least 5 years' residence in the community (village) of the flow transfer sites and those who had not received vitamin D preparations or calcium supplements in the last three months.

Exclusion criteria: missing data and outliers in the questionnaire; subjects with diabetes history; pregnant women; subjects with thyroid dysfunction with or without medication; subjects with parathyroid disease history; patients with severe liver and kidney dysfunction; patients with recent acute infection; subjects with newly broken bones, and those who recently took vitamin D, hormones and other drugs that affect blood calcium and vitamin D metabolism.

Methods {#S0002-S2002}
-------

### Collection of Basic Information of the Subjects {#S0002-S2002-S3001}

The volunteers' basic information, education level, drinking history, smoking history, diabetes and hypertension history, family history of coronary heart disease, dietary and living habits (including milk, calcium and vitamin D supplements, etc.) were collected. The subjects were also asked whether they had metabolic osteopathy, thyroid diseases, severe hepatic and renal insufficiency, or malignant tumors. Height, weight, waist circumference (WC), systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate were measured. The height and weight of the subjects were measured by professional medical staff, and the subjects were required to take off their shoes and wear thin clothing. Body mass index (BMI) was calculated by dividing weight by height squared (Kg/m^2^). WC was measured at the umbilical plane. Heart rate, SBP and DBP were read with an electronic sphygmomanometer after a 10-minute rest.

### Determination of Serum Biochemical Indicators {#S0002-S2002-S3002}

After fasting overnight for 8 h, the venous blood samples were collected in the morning. The fasting plasma glucose (FPG), 2 h postprandial plasma glucose (H~2~PG), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and blood calcium (Ca) were measured using the Bs-220 automatic biochemical analyzer (Mairui Biotechnology Co. Ltd., China). The reagents were purchased from Meigao medical technology Co. Ltd., China.

Diagnostic Standards {#S0002-S2003}
--------------------

Serum 25(OH)D \<20 ng/mL (50 nmol/L) was defined as vitamin D deficiency, 20--30 ng/mL (50--75 nmol/L) as vitamin D insufficient, and \>30 ng/mL (\>75 nmol/L) as vitamin D sufficient.[@CIT0013]

According to the American Diabetes Association (ADA) recommendations, diabetes mellitus is recognized when FPG ≥7.0 mmol/L or H~2~PG ≥11.1 mmol/L. Impaired Fasting Glucose (IFG): 5.6 mmol/L ≤FPG ≤6.9 mmol/L; Impaired Glucose Tolerance (IGT): 7.8 mmol/L ≤ H~2~PG \<11.0 mmol/L.

Diagnosis of dysglycemia:[@CIT0014] fasting blood glucose ≥5.6 mmol/L; H~2~PG ≥7.8 mmol/L, and any of the above two abnormalities is defined as dysglycemia.

Diagnosis of dyslipidemia:[@CIT0015] TG ≥1.70 mmol/L; TC ≥5.2 mmol/L; LDL-C ≥3.4 mmol/L; HDL-C \<1.04 mmol/L; and any of the above is considered as dyslipidemia.

Statistical Analysis {#S0002-S2004}
--------------------

All data were analyzed using SPSS25.0. Measurement data are expressed as mean ± standard deviation ($\documentclass[12pt]{minimal}
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\end{document}$). Independent sample *t*-test was used for the comparison of normal distribution data between two groups. One-way ANOVA was used for the comparison between multiple groups, and LSD method was used for the pairwise comparison. Non-normal distribution data were tested by non-parametric test. The counting data were compared between the two groups using the chi-square test. The correlations between serum vitamin D levels and glucose and lipid metabolism were analyzed by Pearson's correlation analysis. Multivariate linear regression analysis was performed to analyze the independent factors influencing serum vitamin D levels. Since gender as a discontinuous variable, we converted gender into a dummy variable in regression analysis, with 0 for males and 1 for females. A *p*-value\<0.05 was considered as statistically significant.

Results {#S0003}
=======

Comparison of 25(OH)D Levels with Different Characteristics of the Population {#S0003-S2001}
-----------------------------------------------------------------------------

The mean age of the 1928 participants was 42.9 years, of which 35 (1.8%) had adequate levels of 25(OH) D, 212 (11.0%) had inadequate levels, and 1681 (87.2%) were considered as deficient. When stratified by gender, 794 (82.9%) males and 887 (91.4%) females were 25(OH) D deficient ([Table 1](#T0001){ref-type="table"}).Table 1Comparison of Vitamin D Levels Among Subjects with Different CharacteristicsVariablesGroupNumber (N)Values $\documentclass[12pt]{minimal}
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(%)25(OH)D Concentrations (mmol/L)*P*Age (years)18--44108931.89±6.7256.514.61±5.860.00145--5953650.93±4.2927.813.60±5.83≥6030368.34±6.3415.713.45±6.36GenderMale958-49.715.46±6.010.000Female970-50.312.85±5.61BMI (kg/m^2^)\<18.58017.68±0.654.114.33±5.510.12≥18.5 and\<24.092721.67±1.4448.113.69±5.99≥24.0 and\<28.071425.64±1.1237.014.63±6.00≥2820730.11±1.8910.814.46±5.62Glycemic status (mmol/L)FPG\<5.614924.90±0.4877.314.37±6.020.002FPG≥5.64366.31±1.4422.713.35±5.65H~2~PG\<7.815166.13±0.8178.614.19±5.940.492H~2~PG≥7.841210.17±3.2221.413.97±5.99Lipid levels (mmol/L)TC\<5.215824.07±0.6682.014.19±5.890.475TC≥5.23465.87±0.5918.013.93±6.25TG\<1.713781.05±1.3271.514.34±5.980.024TG≥1.75502.85±1.3928.513.66±5.85LDL-C\<3.416712.41±0.5486.714.16±5.910.818LDL-C≥3.42573.89±0.5513.314.06±6.21HDL-C≥1.0417761.54±0.3592.114.10±5.940.217HDL-C\<1.041520.93±0.117.914.72±6.13Blood glucose levelNormal1296-67.214.43±5.980.01IGT/IFG526-27.313.51±5.92Diabetes106-5.513.86±5.46DyslipidemiaNo1102-57.214.40±5.990.027Yes826-42.813.80±5.89[^1]

Vitamin D levels were significantly lower in the ≥60 years age group than in the 18--44 and 45--59 years age groups (*p*=0.001). There was no significant difference in serum vitamin D levels between the 18--44 and 45--59 years age groups. Vitamin D levels were significantly higher in men than in women (*p*\<0.001) ([Table 1](#T0001){ref-type="table"}). There was no significant difference in serum vitamin D levels among different BMI groups ([Table 1](#T0001){ref-type="table"}).

Among the 1928 participants, 106 (5.5%) cases were newly diagnosed with diabetes and 526 (27.3%) had IGT/IFG. The serum vitamin D levels of the diabetic group and the IGT/IFG group were significantly lower than that of the normal blood glucose group. There was no significant difference in vitamin D levels between the diabetic group and the IGT/IFG group. The level of vitamin D in the FPG ≥5.6 mmol/L group was significantly lower than that in the FPG \<5.6 mmol/L group (*p*=0.002). Vitamin D levels between the H~2~PG \<7.8 mmol/L group and the H~2~PG≥7.8 mmol/L group showed no statistical difference ([Table 1](#T0001){ref-type="table"}).

The serum vitamin D levels in the dyslipidemia group were significantly lower than that in the normal group ([Table 1](#T0001){ref-type="table"}). The serum vitamin D level of the TG ≥1.7 mmol/L group was significantly lower than that of the TG \<1.7 mmol/L group (*p*=0.0274). There was no significant difference in serum vitamin D levels between the groups with different TC, HDL-C, and LDL-C levels ([Table 1](#T0001){ref-type="table"}).

Comparison of Relevant Indexes Among the Different 25(OH)D Level Groups {#S0003-S2002}
-----------------------------------------------------------------------

The number of cases in the vitamin D sufficient group was small (n=35), therefore, the vitamin D sufficient group and the vitamin D insufficient group (n=212) were combined into one group. According to the dichotomy, vitamin D levels were divided into the vitamin D deficiency group 25(OH)D \<20 ng/mL (\<50 nmol/L) and the non-vitamin D deficiency group 25(OH)D ≥20 ng/mL (≥50 nmol/L), respectively.

The age, heart rate, TG, TC, FPG and H~2~PG levels of the vitamin D deficiency group were significantly higher than that of the non-vitamin D deficiency group (*p*\<0.05), while the blood Ca level was significantly lower than that of the non-vitamin D deficiency group (*p*\<0.05) ([Table 2](#T0002){ref-type="table"}).Table 2Comparison of Indicators Between Vitamin D Deficiency Group and Non-Vitamin D Deficiency Group ($\documentclass[12pt]{minimal}
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\end{document}$)IndicatorsVitamin D Deficiency Group \<20 ng/mL (n=1681)Non-Vitamin D Deficiency group≥20 ng/mL (n=247)*p*-valueMales (Female)794(887)164(83)\<0.0001Age (years)43.46±14.8939.16±15.28\<0.0001BMI (Kg/m^2^)23.87±3.3423.98±3.330.626SBP (mmHg)126.31±18.57124.31±15.940.109DBP (mmHg)77.73±11.6377.12±10.720.436WC (cm)83.46±9.9584.92±9.800.032Heart rate (beats/min)80.42±12.1078.40±11.800.014TG (mmol/L)1.58±1.161.41±0.910.027TC (mmol/L)4.42±0.954.26±0.950.012LDL-C (mmol/L)2.62±0.742.53±0.740.067HDL-C (mmol/L)1.50±0.371.47±0.390.162FPG (mmol/L)5.24±1.035.10±0.720.040H~2~PG (mmol/L)7.04±2.406.72±1.830.042Ca (mmol/L)2.20±0.122.22±0.180.00825(OH)D (ng/mL)12.49±3.8825.39±5.40\<0.0001[^2]

Prevalence of Dyslipidemia and Dysglycemia in the Different 25(OH)D Groups {#S0003-S2003}
--------------------------------------------------------------------------

The prevalence of FPG ≥5.6 mmol/L in the vitamin D deficiency group was significantly higher than that in the non-vitamin D deficiency group (23.5% *vs* 16.6%, *p*=0.016). In addition, the prevalence of TG ≥1.70 mmol/L in the vitamin D deficiency group was higher than that in the non-vitamin D deficiency group (29.3% *vs* 23.5%), but did not reach statistical significance (*p*=0.06) ([Figure 1](#F0001){ref-type="fig"})Figure 1The prevalence of dysglycemia and dyslipidemia in different 25(OH)D groups.

Relationship Between 25(OH)D Level and Glucose and Lipid Metabolism {#S0003-S2004}
-------------------------------------------------------------------

Pearson's correlation analysis showed that serum 25(OH)D levels were negatively correlated with serum TG (r=−0.067, *p*=0.003), HDL-C (r=−0.050, *p*=0.029), FPG (r=−0.063, *p*=0.006), age (r=−0.116, *p*\<0.001), and heart rate (r=−0.077, *p*=0.001). Moreover,serum 25(OH)D levels were positively correlated with serum calcium level (r=0.078, *p*=0.001). There was no correlation between LDL-C, SBP and DBP levels ([Table 3](#T0003){ref-type="table"}).Table 3Correlation Analysis of 25(OH) D and Various Metabolic Indexesr*p*Age−0.2190.000WC0.0900.000BMI0.0510.026SBP−0.0310.171DBP−0.0170.453Heart rate−0.0770.001TC−0.0300.191TG−0.0670.003HDL-C−0.0500.029LDL-C−0.0240.331FPG−0.0630.006H~2~PG−0.0380.094Ca0.0780.001[^3]

Multiple Linear Regression Analysis {#S0003-S2005}
-----------------------------------

With serum 25(OH)D level as the dependent variable, and FPG, H~2~PG, TG, TC, LDL-C, HDL-C, WC, blood Ca and heart rate as independent variables, multiple linear regression analysis suggested that FPG (β=−0.069, *p*=0.038), TG (β=−0.113, *p*=0.000), LDL-C (β=−0.086, *p*=0.037) and heart rate (β=−0.073, *p*=0.002) were independently and negatively correlated with serum 25(OH)D level. Blood Ca levels were independently and positively correlated with vitamin D levels (β=0.079, *p*=0.000). After further adjustments for age, gender and BMI, serum 25(OH)D levels were independently correlated with gender (β=−0.218, *p*\<0.001), age (β=−0.129, *p*\<0.001), FPG (β=−0.075, *p*=0.021), TG (β=−0.103, *p*\<0.001), and heart rate (β=−0.058, *p*=0.011) ([Table 4](#T0004){ref-type="table"}).Table 4Multiple Linear Regression Analysis of Vitamin D and Various Metabolic IndexesModel 1Model 2Bβ*P*Bβ*P*Gender------ Males0^a^ Female−2.592−0.2180.000Age------−0.051−0.1290.000BMI------0.0520.0290.433FPG−0.413−0.0690.038−0.449−0.0750.021H~2~PG0.0740.0290.3900.1540.0600.070TG−0.595−0.1130.000−0.540−0.1030.000TC0.4360.0690.1100.3370.0540.207LDL-C−0.688−0.0860.037−0.342−0.0430.297HDL-C−0.797−0.0510.0930.0610.0040.897WC0.0700.1170.0000.0190.0320.411Ca3.5820.0790.0001.8370.0410.077Heart rate−0.036−0.0730.002−0.029−0.0580.011[^4]

Discussion {#S0004}
==========

25(OH)D, the main form of vitamin D in the blood circulation, reflects the nutritional status of vitamin D. 1, 25-dihydroxyvitamin D is the main bioactive form of vitamin D, which exerts biological effects by binding to vitamin D receptor (VDR).[@CIT0001] At present, the definition of vitamin D deficiency remains controversial. According to the guidelines of the United States in 2011[@CIT0013] and the clinical consensus of vitamin D and its analogs in China in 2018,[@CIT0016] vitamin D deficiency is defined as 25(OH)D \<20 ng/mL.A systematic review showed that vitamin D deficiency was prevalent in most regions of China.[@CIT0017] In this study, the prevalence of vitamin D deficiency in Gansu (Western China) was 87.2%, which was higher than that in other Chinese cities.[@CIT0018]--[@CIT0021] It was also higher than in some foreign countries, such as Japan (40.8%), Finland (69%), Spain (30.5%) and Iran (71.2%).[@CIT0022]--[@CIT0025] The disparity may be due to the fact that Gansu is relatively underdeveloped economically and inland, where people eat fewer foods rich in vitamin D, such as fish. Gansu province is located in latitude of 32°31"-42°57"N and longitude of 92°13"-108°46"E. It is far from the equator and ultraviolet radiation intensity is weaker, leading to less vitamin D synthesis in the skin. In addition, vitamin D levels are generally higher in summer than in winter, which may be related to UV intensity.[@CIT0026],[@CIT0027]

Vitamin D, as the main regulator of calcium and phosphorus metabolism, plays an important role in maintaining intracellular and extracellular calcium homeostasis. In addition to its association with bone health, vitamin D is also associated with obesity, insulin resistance, diabetes, hypertension, atherosclerosis and other diseases.[@CIT0016] In this study, the relationship between vitamin D and glucose and lipid metabolism as well as blood calcium and heart rate was analyzed. The results showed that vitamin D was negatively correlated with FPG, TG and TC, and after adjusting for gender, age and BMI, vitamin D was negatively correlated with FPG and TG. Previous studies have shown a close relationship between vitamin D levels and glycolipid metabolism. Most observational studies have shown that vitamin D was negatively correlated with FPG,[@CIT0021],[@CIT0028]-[@CIT0030] TG,[@CIT0024],[@CIT0028]-[@CIT0033] TC,[@CIT0028],[@CIT0030],[@CIT0034],[@CIT0035] LDL-C[@CIT0024],[@CIT0028],[@CIT0031] and positively correlated with serum HDL-C.[@CIT0024],[@CIT0028],[@CIT0031],[@CIT0034] Szternel et al[@CIT0029] showed that serum vitamin D level was negatively correlated with FPG and TC in children aged 9--11 years, and every 1 ng/mL reduction in 25(OH)D concentration was associated with a 0.013 mmol/L increase in FPG, a 0.25 mmol/L increase in TC, and a 0.015 mmol/L decrease in HDL-C.

Some potential mechanisms have been suggested to explain the role of vitamin D deficiency in insulin resistance,[@CIT0035],[@CIT0036] because the vitamin D by the pancreas and nerve tissue of the VDR directly stimulates the production of insulin, and vitamin D deficiency may indirectly affect the variations of calcium level during insulin secretion, signal transduction and the activity of glucose transporter. In addition, insulin secretion is a calcium-dependent process, and vitamin D indirectly regulates the function of cells by regulating extracellular calcium and calcium fluxes. So a lack of vitamin D or calcium intake may alter the stability of the intracellular and extracellular calcium pools, which in turn may affect the normal secretion of insulin. In an animal study, VDR knock-out mice consumed more energy and oxygen than wild-type mice. Therefore, they had less body fat and lower plasma TG and TC levels.[@CIT0037] Vitamin D can improve lipid metabolism by inhibiting parathyroid hormone (PTH) secretion (PTH can reduce fat breakdown) and increasing blood calcium level (calcium can reduce the formation and secretion of liver TG).[@CIT0016] Vitamin D supplementation may reduce the rate of conversion from pre-diabetes to diabetes, and the incidence of obesity.[@CIT0038]

Consistent with previous studies,[@CIT0018],[@CIT0028],[@CIT0039] vitamin D levels were negatively correlated with age in this study, and lower vitamin D concentrations were observed with the increase in age. This has been linked to a decline in the ability of older people's skin to synthesize vitamin D.[@CIT0001] However, Nakhaee et al[@CIT0025] reported that the age of the vitamin D sufficient group was higher than that of the non-deficient and deficient groups. In addition, the vitamin D level of women was lower than that of men in the present study, which was consistent with previous studies,[@CIT0018],[@CIT0021],[@CIT0028],[@CIT0030] and may be related to the different lifestyles of men and women, as many women used sunblock products or performed fewer outdoor activities.

The relationship between vitamin D levels and obesity is inconsistent. Most studies suggested that vitamin D levels were lower in obese people, and negatively correlated with BMI[@CIT0022],[@CIT0026],[@CIT0027],[@CIT0032] and WC.[@CIT0030],[@CIT0032],[@CIT0034] The possible mechanism is that excessive vitamin D accumulates in the adipose tissue of obese people, leading to a decrease in vitamin D in the blood circulation and affecting its biological activity. Similarly, vitamin D inhibits the differentiation of pre-adipocytes into adipocytes, thereby reducing the production of fat. However, our study showed no significant correlation between vitamin D concentration and BMI. This may be related to dietary characteristics, ethnic differences, physical activity levels and education levels in different study populations, especially in foreign populations and more obese people.

Previous studies have found that the regulation of 1,25(OH)D on renin does not depend on the metabolism of calcium, but inhibits the production of renin through a mechanism mediated by VDR. Therefore, 1,25(OH)D is believed to be a negative regulator of renin-angiotensin system, which can prevent and improve hypertension.

Some studies have shown a significant negative correlation between serum vitamin D levels and SBP, or DBP levels.[@CIT0023],[@CIT0032] However, the current results suggest that serum vitamin D levels are not correlated with SBP and DBP levels. Consistent with our results, Kwon et al[@CIT0040] reported that serum vitamin D levels were not correlated with blood pressure. The reason for the inconsistent results may be that hypertension is a multifactorial disease, and interactions with race, age, diet, or other factors may weaken the association between vitamin D and blood pressure. More well-designed studies are needed to clarify the issue in the future.

There are few studies on the relationship between heart rate and vitamin D. In the current study, vitamin D was negatively correlated with heart rate. Studies have shown that vitamin D was associated with cardiac autonomic nerve activity,[@CIT0023],[@CIT0041] therefore, people with vitamin D deficiency may have a higher resting heart rate. The increased resting heart rate may also affect blood glucose and lipid levels.[@CIT0042] Consistent with our results, Ke et al[@CIT0023] found that vitamin D levels were negatively correlated with heart rate at baseline and after four years, even after adjusting for related confounding factors. Holick et al[@CIT0013] reported a similar correlation between vitamin D and heart rate.

In summary, the present study suggested that the prevalence of vitamin D deficiency in Gansu province was relatively high, and the incidence of abnormal glucose and lipid levels in the vitamin D deficiency group was relatively high. Vitamin D was negatively correlated with FPG and TG, positively correlated with blood Ca, but not significantly correlated with WC, BMI and blood pressure. However, there were limitations to this study, which was a cross-sectional study, and could not show a causal relationship between vitamin D deficiency and abnormal glucose and lipid metabolism. In addition, the study did not exclude confounding factors such as exposure to sunlight, smoking and work environment. Moreover, data such as insulin levels and parathyroid hormone levels were not collected in the study, so the correlation between vitamin D and insulin resistance could not be better evaluated. The sample size of this study was small. Furthermore, there is a percentage of individuals who are affected by diabetes, but that do not know to have this disease and that possibly have been enclosed in this study, which may influence the results. Hence, more prospective studies are needed to further explore the effects of vitamin D deficiency on dysglycemia, and whether appropriate vitamin D supplementation is beneficial for improving dysglycemia.

Conclusions {#S0005}
===========

The incidence of dyslipidemia and dysglycemia was higher in the vitamin D deficiency group. The level of vitamin D was independently and negatively correlated with FPG and TC, but not with waist circumference, BMI and blood pressure.
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